联网给药装置市场规模、份额和趋势分析报告:按产品、给药途径、应用(哮喘、慢性阻塞性肺病、糖尿病管理、其他)、地区、细分市场2023-2030预测
市场调查报告书
商品编码
1170997

联网给药装置市场规模、份额和趋势分析报告:按产品、给药途径、应用(哮喘、慢性阻塞性肺病、糖尿病管理、其他)、地区、细分市场2023-2030预测

Connected Drug Delivery Devices Market Size, Share & Trends Analysis Report By Product, By Route Of Administration (Parenteral, Inhalational), By Application (Asthma, COPD, Diabetes Management, Others), By Region, And Segment Forecasts, 2023 - 2030

出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10个工作天内

价格

互联给药装置的市场增长和趋势

根据 Grandview Research 的一份新报告,到 2030 年,全球联网给药设备市场预计将达到 256.3 亿美元。从 2023 年到 2030 年,该市场预计将以 23.45% 的复合年增长率增长。市场增长的主要驱动力包括提高患者服药依从性、研发计划以及加速远程数字监控的需求。例如,2022 年 9 月,Ypsomed 与 Sidekick Health 合作,将自我注射模块整合到 Sidekick 已知的数字治疗解决方案中,以扩展 Ypsomed 的设备和 SmartServices 产品。这将使慢性病患者能够通过整合 Ypsomed 的设备和 Sidekick 在数字健康行为经济学和游戏化方面的专业知识,获得个性化的患者体验,而製药客户将获得集成服务和先进的数字治疗管理系统。

一项技术进步是连接药物输送,它配备了传感器,可以通过蜂窝、蓝牙和 NFC(近场通信)网络与服务器和应用程序进行通信和数据传输。这些联网药物输送的主要好处之一是为患者提供提醒和依从性追踪器,减少遵守规定用药时间表所需的努力。这将进一步减少处方浪费,尤其是需要保险的生物注射剂。连接的药物输送系统还允许医生监测患者对推荐治疗的依从性并根据需要修改患者治疗。例如,连接的药物输送设备可以帮助管理患有糖尿病和哮喘等慢性病的患者的自我药疗。未来几年,这些因素预计将加速市场增长。

慢性阻塞性肺病、糖尿病和哮喘等慢性病的全球发病率上升预计将推动互联给药设备的业务发展。例如,国家医学图书馆和国家生物技术信息中心于 2022 年 1 月发表的一项关于 2021 年糖尿病患病率估计的研究发现,2021 年 20 至 79 岁人群的疾病患病率为 10.5%,估计将增加到 12.2 2045 年的百分比。糖尿病被认为对男性和女性的影响相同,但最常见于 75 至 79 岁的人群。此外,随着具有更大优势的联网给药装置的普及,手动给药装置越来越多地被取代。预计这些因素将推动相关药物市场的增长。

全球 COVID-19 大流行产生了负面影响,增加了对医疗保健服务的需求。这正在加速重新设计医疗保健系统以改善支持和技术快速发展的趋势。2020 年,全球大多数市场都在下滑,但儘管大多数国家条件艰难且处于封锁状态,但市场却出现了前所未有的增长。锁定限制导致对家庭护理中使用的药物输送系统的需求意外增加,这也增加了对联网药物输送设备的需求。

这份报告,“联网药物输送设备市场规模、份额和趋势分析报告,按产品(联网传感器、集成联网设备)、按给药途径(肠胃外、吸入)、按应用(哮喘、慢性阻塞性肺病、糖尿病管理)”, Grandview Research 客户现在可以获得 2022-2030 年区域和细分市场预测,也可以直接从以下渠道购买:

连接的药物输送设备市场报告要点

2022 年全球市场价值 48.4 亿美元,预计预测期内復合年增长率为 23.45%

由于对连接传感器的需求不断增长,独立组件和软件部分将在预测期内增长,这些连接传感器将传统的药物输送设备转换为连接的药物输送设备而不干扰其正常功能,即使设备是一次性的也可以重复使用。期间获得最高的收入份额

由于智能和连接的肠外设备与传统设备相比具有众多优势,预计在预测期内,肠外部分将推动市场增长。

到 2022 年,糖尿病管理以超过 36.23% 的份额占据市场主导地位。这是由于糖尿病患病率上升、技术进步以及胰岛素输送装置的研发等因素造成的。

预计北美将在预测期内主导市场。这是由于该地区人均医疗保健支出高、大公司的技术实力迅速增长以及越来越多地采用远程监控药物依从性。

目录

第一章 调查方法和范围

  • 市场细分和范围
    • 估计/预测时间表
  • 调查方法
  • 信息采购
    • 购买的数据库:
    • GVR 内部数据库
    • 次要信息
    • 初步调查:
    • 第一次调查的内容
  • 信息或数据分析
    • 数据分析模型
  • 市场製定和验证
  • 型号详情
    • 商品流向分析
  • 二级信息列表
  • 目的

第二章执行摘要

  • 市场快照
  • 段快照
  • 竞争格局的快照

3 联网药物输送设备市场:市场变量的趋势和范围

  • 市场系列展望
    • 母市场分析
    • 补充市场分析
  • 绘製渗透率和增长前景
  • 市场动态
    • 市场驱动力分析
    • 市场约束因素分析
    • 市场机会分析
    • 市场问题分析
  • 行业分析
    • 波特五力分析
      • 买方议价能力
      • 供应商的议价能力
      • 新进入者的威胁
      • 替代品的威胁
      • 行业竞争力:高
    • PESTEL 分析
      • 政治和法律环境
      • 经济社会形势
      • 环境状况
      • 科技景观
  • 研发及产品管线分析
  • 价格分析
  • 监管和报销框架
  • 互联给药设备市场:COVID-19 影响分析

4 联网给药设备市场:产品分析

  • 2022 年和 2030 年产品市场份额分析
  • 联网给药设备市场:产品变化分析,2018-2030
    • 独立组件和软件
    • 集成设备

5 联网给药装置市场:给药途径分析

  • 2022 年和 2030 年行政管理市场份额分析
  • 联网给药装置市场:给药途径的变化分析,2018-2030
    • 肠外
    • 吸入

6 联网给药设备市场:应用分析

  • 2022 年和 2030 年应用市场份额分析
  • 联网给药设备市场:应用变化分析,2018-2030
    • 哮喘
    • 慢性阻塞性肺病
    • 糖尿病管理
    • 其他

7 互联给药设备市场:区域市场分析、副产品、给药途径、应用、分销渠道 2018-2030(百万美元)

  • 2022 年和 2030 年区域市场份额分析
  • 区域市场快照
  • 北美
    • 美国
    • 加拿大
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 西班牙
    • 意大利
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳大利亚
    • 韩国
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 多边环境协定
    • 南非
    • 沙特阿拉伯

8 连接药物输送设备市场-竞争分析

  • Teva Respiratory, Llc
    • 公司简介
    • 财务绩效
    • 产品基准
    • 战略举措
  • Novo Nordisk A/S
    • 公司简介
    • 财务绩效
    • 产品基准
    • 战略举措
  • Phillips-Medisize, Llc
    • 公司简介
    • 财务绩效
    • 产品基准
    • 战略举措
  • Medtronic
    • 公司简介
    • 财务绩效
    • 产品基准
    • 战略举措
  • Adherium Limited
    • 公司简介
    • 财务绩效
    • 产品基准
    • 战略举措
  • Tandem Diabetes Care, Inc.
    • 公司简介
    • 财务绩效
    • 产品基准
    • 战略举措
  • Biocorp
    • 公司简介
    • 财务绩效
    • 产品基准
    • 战略举措
  • Propeller Health
    • 公司简介
    • 产品基准
    • 战略举措
  • Ypsomed Ag
    • 公司简介
    • 财务绩效
    • 产品基准
    • 战略举措
  • Aptar Pharma
    • 公司简介
    • 财务绩效
    • 产品基准
    • 战略举措
  • 市场参与的分类
  • 公司市场分析
  • 主要公司名单
Product Code: GVR-2-68038-651-6

Connected Drug Delivery Devices Market Growth & Trends

The global connected drug delivery devices market size is expected to reach USD 25.63 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a lucrative CAGR of 23.45% from 2023 to 2030. Key factors driving the market growth include the need to increase patient medication adherence, R&D initiatives, and the acceleration of remote digital monitoring. In September 2022, Ypsomed for instance, partnered with Sidekick Health to expand Ypsomed's device and SmartServices offering by incorporating a self-injection module into Sidekick's known digital therapeutics solution. Through this, patients with chronic diseases are likely to receive a personalized patient experience due to the integration of Ypsomed's devices with Sidekick's digital health behavioral economics and gamification expertise, and pharmaceutical customers will benefit from a comprehensive service, and leading digital therapy management system.

One of the technological advancements is connected drug delivery, which has a sensor that enables communication and data transfer to servers and apps over cellular, Bluetooth, and Near Field Communication (NFC) networks. One of the main benefits of these connected drug delivery systems is that it gives patients reminders and adherence trackers, reducing the effort needed to comply with the prescribed medication schedule. This further reduces the cost of prescription waste, especially that from the increasingly popular biological injectable drugs that insurance would be required to pay for. Additionally, doctors can monitor how well their patients are adhering to their recommended therapies owing to connected drug delivery systems and change the patient's care as appropriate. For instance, connected drug delivery devices can be beneficial to manage self-medication in persons with chronic diseases like diabetes and asthma. In the upcoming years, these factors are anticipated to accelerate market growth.

Worldwide rising rates of chronic illnesses like COPD, diabetes, and asthma are anticipated to propel the business of connected drug delivery devices. For instance, according to research on estimates of diabetes prevalence for 2021 that was published in January 2022 by the National Library of Medicine and National Center for Biotechnology Information, the disease prevalence among people aged 20 to 79 in 2021 was estimated to be 10.5% and could increase to 12.2% by 2045. Diabetes is thought to affect both men and women equally, however, it is most common in people aged 75 to 79. Additionally, as connected drug delivery devices with greater advantages have become more popular, manual drug administration devices have been increasingly replaced. These factors are anticipated to fuel connected drug market growth.

The global COVID-19 pandemic has had a negative impact and raised the need for healthcare services. This has accelerated the trend of redesigning the healthcare system for improved assistance and quick growth of technology. While most global markets went down in 2020, this market showed unprecedented growth despite difficult conditions and a lockdown in most countries. Due to the lockdown restrictions, there was an unexpected rise in demand for drug delivery systems for use in-home care, which resulted in an increase in demand for connected drug delivery devices.

The report "Connected Drug Delivery Devices Market Size, Share & Trends Analysis Report, By Product (Connected Sensors, Integrated Connected Devices), By Route of Administration (Parenteral, Inhalational), By Application (Asthma, COPD, Diabetes Management), By Region, And Segment Forecasts, 2022-2030" is available now to Grand View Research customers and can also be directly purchased from

Connected Drug Delivery Devices Market Report Highlights

  • The global market was valued at USD 4.84 billion in 2022 and is expected to grow at a CAGR of 23.45% during the forecast period
  • The standalone components and software segment is expected to grow for the highest revenue share during the forecast period, owing to the increasing demand for connected sensors to transform traditional drug delivery devices into connected drug delivery devices without interfering with their normal functioning and can be reused even if the device is disposable
  • The parenteral segment is expected to drive market growth during the forecast period, owing to the numerous advantages offered by smart & connected parenteral devices over conventional ones
  • Diabetes Management dominated the market with a share of over 36.23% in 2022. This is owing to factors such as the rising prevalence of diabetes, technological advancements, and R&D in insulin delivery devices
  • North America is expected to dominate the market over the forecast period. This is due to the region's high per capita healthcare spending, rapid adoption of technology presence of key players, and growing adoption of remote monitoring for medication adherence

Table of Contents

Chapter 1 Research Methodology & Scope

  • 1.1 Market Segmentation & Scope
    • 1.1.1 Estimates & Forecast Timeline
  • 1.2 Research Methodology
  • 1.3 Information Procurement
    • 1.3.1 Purchased database:
    • 1.3.2 GVR's Internal Database
    • 1.3.3 Secondary sources
    • 1.3.4 Primary Research:
    • 1.3.5 Details of Primary Research
  • 1.4 Information or Data Analysis
    • 1.4.1 Data Analysis Models
  • 1.5 Market Formulation & Validation
  • 1.6 Model Details
    • 1.6.1 Commodity Flow Analysis
  • 1.7 List of Secondary Sources
  • 1.8 Objectives

Chapter 2 Executive Summary

  • 2.1 Market Snapshot
  • 2.2 Segment Snapshot
  • 2.3 Competitive Landscape Snapshot

Chapter 3 Connected Drug Delivery Devices Market: Market Variables Trends & Scope

  • 3.1 Market Lineage Outlook
    • 3.1.1 Parent Market Analysis
    • 3.1.2 Ancillary Market Analysis
  • 3.2 Penetration And Growth Prospect Mapping
  • 3.3 Market Dynamics
    • 3.3.1 Market Driver Analysis
    • 3.3.2 Market Restraint Analysis
    • 3.2.3 Market Opportunity Analysis
    • 3.2.4 Market Challenge Analysis
  • 3.4 Industry Analysis
    • 3.4.1 Porter's 5 Forces Analysis
      • 3.4.1.1 Bargaining Power of Buyers
      • 3.4.1.2 Bargaining Power of Suppliers
      • 3.4.1.3 Threat of New Entrants
      • 3.4.1.4 Threat of Substitutes
      • 3.4.1.5 Industry Rivalry: High
    • 3.4.2 PESTEL ANALYSIS
      • 3.4.2.1 Political & Legal Landscape
      • 3.4.2.2 Economic & Social Landscape
      • 3.4.2.3 Environmental Landscape
      • 3.4.2.4 Technology Landscape
  • 3.5 R&D/ Product Pipeline Analysis
  • 3.6 Pricing Analysis
  • 3.7 Regulatory & Reimbursement Framework
  • 3.8 Connected Drug Delivery Devices Market: Covid-19 Impact Analysis

Chapter 4 Connected Drug Delivery Devices Market: Product Analysis

  • 4.1 Product Market Share Analysis, 2022 & 2030
  • 4.2 Connected Drug Delivery Devices Market: Product movement analysis, 2018 to 2030
  • 4.3 Standalone Components & Software
    • 4.3.1 Standalone Components & Software market estimates and forecasts, 2018 - 2030 (USD Million)
    • 4.3.2 Integrated Devices
      • 4.3.2.1 Integrated Devices market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 5 Connected Drug Delivery Devices Market: Route of Administration Analysis

  • 5.1 Route of Administration Market Share Analysis, 2022 & 2030
  • 5.2 Connected Drug Delivery Devices Market: Route of Administration movement analysis, 2018 to 2030
  • 5.3 Parenteral
    • 5.3.1 Parenteral market estimates and forecasts, 2018 - 2030 (USD Million)
    • 5.3.2 Inhalational
      • 5.3.2.1 Inhalational market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 6 Connected Drug Delivery Devices Market: Application Analysis

  • 6.1 Application Market Share Analysis, 2022 & 2030
  • 6.2 Connected Drug Delivery Devices Market: Application movement analysis, 2018 to 2030
  • 6.3 Asthma
    • 6.3.1 Asthma market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.3.2 COPD
      • 6.3.2.1 COPD market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.3.3 Diabetes Management
      • 6.3.3.1 Diabetes Management market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.3.4 Others
      • 6.3.4.1 Others market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 7 Connected Drug Delivery Devices Market: Regional Market Analysis, By Product, route of administration, application, distribution channel 2018 - 2030 (USD Million)

  • 7.1 Regional Market Share Analysis, 2022 & 2030
  • 7.2 Regional Market Snapshot
  • 7.3 North America
    • 7.3.1 North America Connected Drug Delivery Devices Market estimates and forecasts by countries, 2018 - 2030 (USD Million)
    • 7.3.2 U.S.
      • 7.3.2.1 U.S. Connected Drug Delivery Devices Market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.3.3 Canada
      • 7.3.3.1 Canada Connected Drug Delivery Devices Market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.4 Europe
    • 7.4.1 Europe Connected Drug Delivery Devices Market estimates and forecasts by countries, 2018 - 2030 (USD Million)
    • 7.4.2 U.K.
      • 7.4.2.1 U.K. Connected Drug Delivery Devices Market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.4.3 Germany
      • 7.4.3.1 Germany Connected Drug Delivery Devices Market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.4.4 France
      • 7.4.4.1 France Connected Drug Delivery Devices Market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.4.5 Spain
      • 7.4.5.1 Spain Connected Drug Delivery Devices Market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.4.6 Italy
      • 7.4.6.1 Italy Connected Drug Delivery Devices Market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.5 Asia Pacific
    • 7.5.1 Asia Pacific Connected Drug Delivery Devices market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.5.2 Japan
      • 7.5.2.1 Japan Connected Drug Delivery Devices Market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.5.3 China
      • 7.5.3.1 China Connected Drug Delivery Devices market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.5.4 India
      • 7.5.4.1 India Connected Drug Delivery Devices market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.5.5 Australia
      • 7.5.5.1 Australia Connected Drug Delivery Devices market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.5.6 South Korea
      • 7.5.6.1 South Korea Connected Drug Delivery Devices market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.6 Latin America
    • 7.6.1 Latin America Connected Drug Delivery Devices Market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.6.2 Brazil
      • 7.6.2.1 Brazil Connected Drug Delivery Devices Market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.6.3 Mexico
      • 7.6.3.1 Mexico Connected Drug Delivery Devices Market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.6.4 Argentina
      • 7.6.4.1 Argentina Connected Drug Delivery Devices Market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.7 MEA
    • 7.7.1 MEA Connected Drug Delivery Devices market estimates and forecasts by countries, 2018 - 2030 (USD Million)
    • 7.7.2 South Africa
      • 7.7.2.1 South Africa Connected Drug Delivery Devices Market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.7.3 Saudi Arabia
      • 7.7.3.1 Saudi Arabia Connected Drug Delivery Devices Market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 8 Connected Drug Delivery Devices Market - Competitive Analysis

  • 8.1 Teva Respiratory, Llc
    • 8.1.1 Company Overview
    • 8.1.2 Financial Performance
    • 8.1.3 Product Benchmarking
    • 8.1.4 Strategic Initiatives
  • 8.2 Novo Nordisk A/S
    • 8.2.1 Company Overview
    • 8.2.2 Financial Performance
    • 8.2.3 Product Benchmarking
    • 8.2.4 Strategic Initiatives
  • 8.3 Phillips-Medisize, Llc
    • 8.3.1 Company Overview
    • 8.3.2 Financial Performance
    • 8.3.3 Product Benchmarking
    • 8.3.4 Strategic Initiatives
  • 8.4 Medtronic
    • 8.4.1 Company Overview
    • 8.4.2 Financial Performance
    • 8.4.3 Product Benchmarking
    • 8.4.4 Strategic Initiatives
  • 8.5 Adherium Limited
    • 8.5.1 Company Overview
    • 8.5.2 Financial Performance
    • 8.5.3 Product Benchmarking
    • 8.5.4 Strategic Initiatives
  • 8.6 Tandem Diabetes Care, Inc.
    • 8.6.1 Company Overview
    • 8.6.2 Financial Performance
    • 8.6.3 Product Benchmarking
    • 8.6.4 Strategic Initiatives
  • 8.7 Biocorp
    • 8.7.1 Company Overview
    • 8.7.2 Financial Performance
    • 8.7.3 Product Benchmarking
    • 8.7.4 Strategic Initiatives
  • 8.8 Propeller Health
    • 8.8.1 Company Overview
    • 8.8.2 Product Benchmarking
    • 8.8.3 Strategic Initiatives
  • 8.9 Ypsomed Ag
    • 8.9.1 Company Overview
    • 8.9.2 Financial Performance
    • 8.9.3 Product Benchmarking
    • 8.9.4 Strategic Initiatives
  • 8.10 Aptar Pharma
    • 8.10.1 Company Overview
    • 8.10.2 Financial Performance
    • 8.10.3 Product Benchmarking
    • 8.10.4 Strategic Initiatives
  • 8.11 Market Participation Categorization
  • 8.12 Company market position analysis
  • 8.13 List of Key Companies

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of key companies
  • Table 3 North America Connected Drug Delivery Devices market, by country, 2018 - 2030 (USD Million)
  • Table 4 North America Connected Drug Delivery Devices market, by Product, 2018 - 2030 (USD Million)
  • Table 5 North America Connected Drug Delivery Devices market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 6 North America Connected Drug Delivery Devices market, by Application, 2018 - 2030 (USD Million)
  • Table 7 U.S. Connected Drug Delivery Devices market, by Product, 2018 - 2030 (USD Million)
  • Table 8 U.S. Connected Drug Delivery Devices market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 9 U.S. Connected Drug Delivery Devices market, by Application, 2018 - 2030 (USD Million)
  • Table 10 Canada Connected Drug Delivery Devices market, by Product, 2018 - 2030 (USD Million)
  • Table 11 Canada Connected Drug Delivery Devices market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 12 Canada Connected Drug Delivery Devices market, by Application, 2018 - 2030 (USD Million)
  • Table 13 Europe Connected Drug Delivery Devices market, by country, 2018 - 2030 (USD Million)
  • Table 14 Europe Connected Drug Delivery Devices market, by Product, 2018 - 2030 (USD Million)
  • Table 15 Europe Connected Drug Delivery Devices market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 16 Europe Connected Drug Delivery Devices market, by Application, 2018 - 2030 (USD Million)
  • Table 17 U.K. Connected Drug Delivery Devices market, by Product, 2018 - 2030 (USD Million)
  • Table 18 U.K. America Connected Drug Delivery Devices market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 19 U.K. Connected Drug Delivery Devices market, by Application, 2018 - 2030 (USD Million)
  • Table 20 Germany Connected Drug Delivery Devices market, by Product, 2018 - 2030 (USD Million)
  • Table 21 Germany Connected Drug Delivery Devices market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 22 Germany Connected Drug Delivery Devices market, by Application, 2018 - 2030 (USD Million)
  • Table 23 France Connected Drug Delivery Devices market, by Product, 2018 - 2030 (USD Million)
  • Table 24 France Connected Drug Delivery Devices market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 25 France Connected Drug Delivery Devices market, by Application, 2018 - 2030 (USD Million)
  • Table 26 Italy Connected Drug Delivery Devices market, by Product, 2018 - 2030 (USD Million)
  • Table 27 Italy Connected Drug Delivery Devices market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 28 Italy Connected Drug Delivery Devices market, by Application, 2018 - 2030 (USD Million)
  • Table 29 Spain Connected Drug Delivery Devices market, by Product, 2018 - 2030 (USD Million)
  • Table 30 Spain Connected Drug Delivery Devices market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 31 Spain Connected Drug Delivery Devices market, by Application, 2018 - 2030 (USD Million)
  • Table 32 Asia Pacific Connected Drug Delivery Devices market, by country, 2018 - 2030 (USD Million)
  • Table 33 Asia Pacific Connected Drug Delivery Devices market, by Product, 2018 - 2030 (USD Million)
  • Table 34 Asia Pacific Connected Drug Delivery Devices market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 35 Asia Pacific Connected Drug Delivery Devices market, by Application, 2018 - 2030 (USD Million)
  • Table 36 China Connected Drug Delivery Devices market, by Product, 2018 - 2030 (USD Million)
  • Table 37 China Connected Drug Delivery Devices market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 38 China Connected Drug Delivery Devices market, by Application, 2018 - 2030 (USD Million)
  • Table 39 Japan Connected Drug Delivery Devices market, by Product, 2018 - 2030 (USD Million)
  • Table 40 Japan Connected Drug Delivery Devices market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 41 Japan Connected Drug Delivery Devices market, by Application, 2018 - 2030 (USD Million)
  • Table 42 India Connected Drug Delivery Devices market, by Product, 2018 - 2030 (USD Million)
  • Table 43 India Connected Drug Delivery Devices market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 44 India Connected Drug Delivery Devices market, by Application, 2018 - 2030 (USD Million)
  • Table 45 Australia Connected Drug Delivery Devices market, by Product, 2018 - 2030 (USD Million)
  • Table 46 Australia Connected Drug Delivery Devices market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 47 Australia Connected Drug Delivery Devices market, by Application, 2018 - 2030 (USD Million)
  • Table 48 South Korea Connected Drug Delivery Devices market, by Product, 2018 - 2030 (USD Million)
  • Table 49 South Korea Connected Drug Delivery Devices market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 50 South Korea Connected Drug Delivery Devices market, by Application, 2018 - 2030 (USD Million)
  • Table 51 LATAM Connected Drug Delivery Devices market, by country, 2018 - 2030 (USD Million)
  • Table 52 LATAM Connected Drug Delivery Devices market, by Product, 2018 - 2030 (USD Million)
  • Table 53 LATAM Connected Drug Delivery Devices market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 54 LATAM Connected Drug Delivery Devices market, by Application, 2018 - 2030 (USD Million)
  • Table 55 Brazil Connected Drug Delivery Devices market, by Product, 2018 - 2030 (USD Million)
  • Table 56 Brazil Connected Drug Delivery Devices market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 57 Brazil Connected Drug Delivery Devices market, by Application, 2018 - 2030 (USD Million)
  • Table 58 Mexico Connected Drug Delivery Devices market, by Product, 2018 - 2030 (USD Million)
  • Table 59 Mexico Connected Drug Delivery Devices market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 60 Mexico Connected Drug Delivery Devices market, by Application, 2018 - 2030 (USD Million)
  • Table 61 Argentina Connected Drug Delivery Devices market, by Product, 2018 - 2030 (USD Million)
  • Table 62 Argentina Connected Drug Delivery Devices market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 63 Argentina Connected Drug Delivery Devices market, by Application, 2018 - 2030 (USD Million)
  • Table 64 MEA Connected Drug Delivery Devices market, by country, 2018 - 2030 (USD Million)
  • Table 65 MEA Connected Drug Delivery Devices market, by Product, 2018 - 2030 (USD Million)
  • Table 66 MEA Connected Drug Delivery Devices market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 67 MEA Connected Drug Delivery Devices market, by Application, 2018 - 2030 (USD Million)
  • Table 68 South Africa Connected Drug Delivery Devices market, by Product, 2018 - 2030 (USD Million)
  • Table 69 South Africa Connected Drug Delivery Devices market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 70 South Africa Connected Drug Delivery Devices market, by Application, 2018 - 2030 (USD Million)
  • Table 71 Saudi Arabia Connected Drug Delivery Devices market, by Product, 2018 - 2030 (USD Million)
  • Table 72 Saudi Arabia Connected Drug Delivery Devices market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 73 Saudi Arabia Connected Drug Delivery Devices market, by Application, 2018 - 2030 (USD Million)
  • Table 74 Global Connected Drug Delivery Devices market, by region, 2018 - 2030 (USD Million)
  • Table 75 Global Connected Drug Delivery Devices market, by Product, 2018 - 2030 (USD Million)
  • Table 76 Global Connected Drug Delivery Devices market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 77 Global Connected Drug Delivery Devices market, by Application, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Data triangulation techniques
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 QFD modeling for market share assessment
  • Fig. 8 Market formulation & validation
  • Fig. 9 Commodity flow analysis
  • Fig. 10 Penetration & growth prospect mapping
  • Fig. 11 Market trends & outlook
  • Fig. 12 Market driver relevance analysis (Current & future impact)
  • Fig. 13 Market restraint relevance analysis (Current & future impact)
  • Fig. 14 Connected Drug Delivery Devices Market product outlook: Key takeaways
  • Fig. 15 Connected Drug Delivery Devices Market: Product movement analysis
  • Fig. 16 Global Standalone components & software market 2018 - 2030 (USD Million)
  • Fig. 17 Global Integrated devices market 2018 - 2030 (USD Million)
  • Fig. 18 Connected Drug Delivery Devices Market Route of Administration outlook: Key takeaways
  • Fig. 19 Connected Drug Delivery Devices Market: Route of Administration movement analysis
  • Fig. 20 Global Parenteral market 2018 - 2030 (USD Million)
  • Fig. 21 Global Inhalational market 2018 - 2030 (USD Million)
  • Fig. 22 Connected Drug Delivery Devices Market Application outlook: Key takeaways
  • Fig. 23 Connected Drug Delivery Devices Market: Application movement analysis
  • Fig. 24 Global Asthma market 2018 - 2030 (USD Million)
  • Fig. 25 Global COPD market 2018 - 2030 (USD Million)
  • Fig. 26 Global Diabetes Management market 2018 - 2030 (USD Million)
  • Fig. 27 Global Others market 2018 - 2030 (USD Million)
  • Fig. 28 Regional outlook, 2022 & 2030
  • Fig. 29 Regional marketplace: Key takeaways
  • Fig. 30 North America Connected Drug Delivery Devices Market by countries, 2018 - 2030 (USD Million)
  • Fig. 31 U.S. Connected Drug Delivery Devices market, 2018 - 2030 (USD Million)
  • Fig. 32 Canada Connected Drug Delivery Devices market, 2018 - 2030 (USD Million)
  • Fig. 33 Europe Connected Drug Delivery Devices market by countries, 2018 - 2030 (USD Million)
  • Fig. 34 U.K. Connected Drug Delivery Devices market, 2018 - 2030 (USD Million)
  • Fig. 35 Germany Connected Drug Delivery Devices market, 2018 - 2030 (USD Million)
  • Fig. 36 France Connected Drug Delivery Devices market, 2018 - 2030 (USD Million)
  • Fig. 37 Spain Connected Drug Delivery Devices market, 2018 - 2030 (USD Million)
  • Fig. 38 Italy Connected Drug Delivery Devices market, 2018 - 2030 (USD Million)
  • Fig. 39 Asia Pacific Connected Drug Delivery Devices market by countries, 2018 - 2030 (USD Million)
  • Fig. 40 China Connected Drug Delivery Devices market, 2018 - 2030 (USD Million)
  • Fig. 41 India Connected Drug Delivery Devices market, 2018 - 2030 (USD Million)
  • Fig. 42 Australia Connected Drug Delivery Devices market, 2018 - 2030 (USD Million)
  • Fig. 43 South Korea Connected Drug Delivery Devices market, 2018 - 2030 (USD Million)
  • Fig. 44 Japan Connected Drug Delivery Devices market, 2018 - 2030 (USD Million)
  • Fig. 45 Latin America Connected Drug Delivery Devices market by countries, 2018 - 2030 (USD Million)
  • Fig. 46 Brazil Connected Drug Delivery Devices market, 2018 - 2030 (USD Million)
  • Fig. 47 Mexico Connected Drug Delivery Devices market, 2018 - 2030 (USD Million)
  • Fig. 48 Argentina Connected Drug Delivery Devices market, 2018 - 2030 (USD Million)
  • Fig. 49 MEA Connected Drug Delivery Devices market by countries, 2018 - 2030 (USD Million)
  • Fig. 50 South Africa Connected Drug Delivery Devices market, 2018 - 2030 (USD Million)
  • Fig. 51 Saudi Arabia Connected Drug Delivery Devices market, 2018 - 2030 (USD Million)
  • Fig. 52 Market Participant categorization
  • Fig. 53 Company market position analysis